*Ladies and Gentlemen
We inform you that the materials and results of the discussions posted on the Agency’s website are the result of the conceptual work and analytical process carried out by the team of the Agency for Health Technology Assessment and Tariff System based on the EBM paradigm, including: search, selection, synthesis and interpretation of scientific evidence, or the data analysis carried out.
In connection with the above, we would like to inform you that the use of analytical material or the results of the discussion, in accordance with good practice, should be accompanied by information on the source in the form: [title of presentation / report], AOTMiT, Warsaw, June 2024]
Agency for Health Technology Assessment and Tariff System
News
all entries17 October 2024
Position of the Transparency Council – Citrulline 200, Citrulline 1000, L-Citrulline
more...AOTMiT's vision and goals
April 1, 2022The Agency's mission is to improve the efficiency of the healthcare system based on EBM and HTA
The AOTMiT in numbers
April 1, 2022Statistics present numerical data on the tasks performed by AOTMiT
Cost Accounting Standard
April 15, 2020Objectives and benefits of SRK implementation Presentations and training materials
Application- Cost Accounting Standard
April 1, 2022Free, innovative tool for cost accounting, procedure pricing, benchmarking and effective management
AOTMiT Library
November 15, 2022We encourage you to review the resources of Agency for Health Technology Assessment and Tariff System’s library, comprising the compendium of knowledge on good practices in health technology assessment and evidence-based medicine.
Medical devices assessment guidelines
April 1, 2022Development of HTA guidelines for non-drug technologies
CEE workshops
April 1, 2022Workshop for Central and Eastern European Countries on Health Technology Assessment (HTA)
Scientific achievements and medical technologies
September 9, 2020Published articles on History of Medical Technology and History of Scientists